Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Edema

• A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
• Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2)
• The Use of Submucosal Dexamethasone After Periodontal Surgery
• Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
• High Versus Low Dose Nitroglycerin in Acute Pulmonary Edema
• Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
• Advair HFA in Healthy and HAPE Predisposed Subjects
• Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
• A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular
• A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macu
• Cool vs Room-temperature Artificial Tears
• Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
• Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
• Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema
• Comparison of Treatments in Diabetic Macular Edema
• Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
• Safety and Effect of Intravitreal Delivery of Zidovudine Derivative, K8, in Subjects With Diabetic Macular Edema
• Effect of AIV007 by Periocular Administration in Subjects With nAMD or DME
• Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema
• RO7200220 in Participants With Uveitic Macular Edema
• A Study to Investigate RO7200220 in Participants With Uveitic Macular Edema
• Study to Assess Safety and Tolerability of Multiple Doses of EO2002
• Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
• A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
• Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept
• Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
• Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
• Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema
• The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)
• Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema
• A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema
• Minocycline Treatment for Cystoid Macular Edema
• Comparison of Hyaluronidase and Dexametasone in Reduction of Postoperative Edema
• Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (AMD) or Subjects With Diabetic Macular Edema (DME).
• Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
• Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema
• Topical Tranexamic Acid Application in Rhinoplasty
• Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema
• Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema
• A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction
• Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions
• Ranibizumab Versus Aflibercept for CRVO in Young Patients.
• Optimized Treatment of Pulmonary Edema or Congestion
• Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular Edema
• Reducing Edema After intraCerebral Hemorrhage
• A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
• Effectiveness of Periocular Drug Injection in CATaract Surgery
• A Study to Investigate RO7200220 in Combination With Ranibizumab in Diabetic Macular Edema
• A Study to Investigate RO7200220 in Diabetic Macular Edema
• An Innovative Chinese Herbal Formula for Macular Edema
• Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema
• Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Diabetic Macular Edema
• A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.
• The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion
• Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema
• A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina
• BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema
• The Effect of Local Tranexamic Acid on Post-operative Edema and Ecchymosis in Eyelid Surgery
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
• Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema
• Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
• Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (DME)
• Ozurdex in Suboptimal Diabetic Macular Edema Patients
• Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
• Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema
• Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema and CRVO
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients
• Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)
• Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO
• A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
• Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.
• A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
• A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema
• Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy
• The PRIME Study: A Randomized, Controlled, Prospective Study
• Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration
• A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
• Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment o
• A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
• A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
• Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema
• Combination of Ranibizumab and Targeted Laser Photocoagulation
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
• Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema
• O2 Versus CPAP Treatment Of Patients Undergoing SIPE Therapy (OCTOPUS)
• Dexamethasone for the Treatment of Vasogenic Pericontusional Edema.
• Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF
• Study 212669: A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
• Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema
• Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
• MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
• Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema
• The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)
• Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
• Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
• Effects of Cold Application and Heparinoid on Periorbital Edema and Ecchymosis
• Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX)
• This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab
• Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema
• Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage
• Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)
• A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion
• Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
• Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery
• To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema
• Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema
• A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema
• The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial)
• One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab
• Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab
• A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated
• Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema
• Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China
• Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema
• A Study Assessing AR-13503 Implant in Subjects With nAMD or DME
• Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
• The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema
• Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
• Combined Ranibizumab and Iluvien for Diabetic Macular Oedema
• Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
• Tacrolimus for Malar Edema
• Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion
• Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention
• A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)
• Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema
• The Study to YD312 Tablet in Patients With Diabetic Macular Edema
• Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
• Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
• Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema
• Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
• Prophylactic Effect of Ketorolac Tromethamine on the Cystoid Macular Edema After Phacoemulsification in Diabetic Patients
• A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)
• A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)
• To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus
• Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography
• A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME)
• Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.
• Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
• Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion
• Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema
• Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE)
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
• Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
• Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME
• Prospective Evaluation of Perioperative Steroid Dosing on Postsurgical Edema in Orthognathic Surgery
• Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
• Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
• Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion
• Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis
• TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
• An Approach to Reduce Uvula Edema After Tonsillectomy
• A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)
• Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab
• Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab
• Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept
• Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study
• Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
• Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
• Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema
• Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
• Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection
• Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema
• Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
• Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study
• Effect of 80-mg Atorvastatin on Myocardial Edema
• 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
• MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial)
• A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema
• Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema
• Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
• The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema
• Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
• Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema
• Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema
• Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
• The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema
• Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
• A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
• A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)
• Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema
• Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
• Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema
• Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study
• Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema
• The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema
• Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema
• Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)
• Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
• Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
• Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
• Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema
• Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.
• Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.
• Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
• Intravitreal Injections of Ziv-aflibercept for Macular Diseases
• Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema
• Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
• Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
• Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema
• A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Co
• Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema
• To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema
• Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)
• The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates
• Topical Nepafenac as Supplement for Diabetic Macular Edema
• Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
• Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema
• Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms
• Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema
• Variable Interval Versus Set Interval Aflibercept for DME
• PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
• The Endurance 1 Trial
• Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME
• A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients
• Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
• Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
• A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
• Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema
• Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
• A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)
• Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
• Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME
• A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients
• Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
• Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
• Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema
• Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema
• Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema
• Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide
• Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
• A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME
• An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
• A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
• Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
• Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema
• Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
• A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
• Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
• A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)
• Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
• Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification
• Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema
• Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema
• Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial
• The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema
• Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
• Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema
• Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase
• Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO
• Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema
• Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
• Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)
• A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
• Safety and Efficacy of Ranibizumab for Diabetic Macular Edema
• Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
• Study of Stroke Related Edema Treatments
• Diabetic Macular Edema Treated With Ozurdex (DMEO)
• Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
• Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome
• Phase II Combination Steroid and Anti-VEGF for Persistent DME
• Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
• A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema
• A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
• Treatment for CI-DME in Eyes With Very Good VA Study
• A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion
• Hyper-CL™ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema
• Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)
• TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
• NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
• To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema
• Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab
• Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment
• Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema
• AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema
• A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema
• Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
• Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
• Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery
• Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
• PRevention of Macular EDema After Cataract Surgery
• Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy
• Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)
• Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)
• Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo
• Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
• Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema
• Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema
• Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy
• A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)
• Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye
• Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops
• Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)
• Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema
• Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
• Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
• Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
• Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)
• Ranibizumab and Bevacizumab for Diabetic Macular Edema
• Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
• Effects of Hyperbaric Oxygen Therapy on Surgical Wound Healing
• Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema
• A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
• Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
• Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion
• A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Ed
• The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
• Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE)
• Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
• Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
• Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema
• Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)
• Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
• Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema
• A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
• Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
• Safety Study of ALG- 1001 to Treat Diabetic Macular Edema
• Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
• Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
• Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
• Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
• Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
• PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
• A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
• An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)
• Dextromethorphan for Diabetic Macular Edema
• Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion
• Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
• Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
• Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema
• Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome
• NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
• Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
• Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
• A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema
• Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
• Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study
• Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
• Ranibizumab "Treat and Extend" in Diabetic Macular Edma
• Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus
• Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab
• Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
• A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
• Ozurdex for Macular Edema Post Membrane Peeling
• Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
• Ranibizumab as a Rescue Therapy for Diabetic Macular Edema
• Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
• Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
• Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema
• Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema
• Intravitreal Macugen for Ischaemic Diabetic Macular Oedema
• Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus
• Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema
• Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
• Safety and Efficacy of Ranibizumab in Diabetic Macular Edema
• Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
• A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema
• MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2)
• A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
• Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
• Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention
• Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS)
• Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)
• Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema
• Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)
• Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema
• Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema
• Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion
• Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion
• Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
• Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
• Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
• Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
• Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema
• Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
• The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema
• Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
• Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)
• Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema
• Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids
• Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
• Prevention and Treatment of Immersion Pulmonary Edema
• Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion
• Avastin for Post-Photocoagulation Macular Edema
• Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery
• Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
• Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
• Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
• Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema
• Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies
• Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina
• Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema
• Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema
• Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.
• Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema
• Intravitreal Bevacizumab for Diabetic Macular Edema
• A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)
• Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)
• A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study
• Effect of Choline Fenofibrate (SLV348) on Macular Edema
• Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
• Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study
• Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
• Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
• Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema
• A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.
• Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study
• Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%
• Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus
• Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema
• A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO
• POSTERIOR SUB-TENON'S Avastin
• Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
• Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
• A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)
• Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)
• Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-traumatic Osteonecrosis of the Knee: A Randomized Double-blind, Placebo-controlled Trial
• A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
• Treatment of Refractory Diabetic Macular Edema With Infliximab
• Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema
• Lucentis for Inflammatory Macular Edema Trial
• Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
• Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery
• Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
• Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)
• Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
• A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)
• A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)
• Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
• Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema
• A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
• Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
• Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema
• Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
• Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema
• Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
• A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)
• The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study
• Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions
• Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
• Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
• Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
• Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema
• To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema
• Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
• Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
• A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema
• A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
• The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema
• Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
• Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema)
• Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
• Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
• A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
• Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema
• Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease
• Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement
• Efalizumab to Treat Uveitis
• Prevention of High Altitude Pulmonary Edema
• A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)
• Triamcinolone vs. Laser for Diabetic Macular Edema
• XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
• Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids
• A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema
• A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
• Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)
• Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
• A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema
• A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema
• Effect of Ruboxistaurin on Clinically Significant Macular Edema
• Study to Treat Uveitis Associated Macular Edema
• Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage
• Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation
• The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study
• XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
• Laser and Antioxidant Treatment of Diabetic Macular Edema
• Research Study in Patients With Persistent Macular Edema
• Laser and Medical Treatment of Diabetic Macular Edema
• Vitamin E to Treat Uveitis-Associated Macular Edema
• Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema